<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H775CA0176511431B82207F415B951CB6" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 1060 IH: Modern Authentication of Pharmaceuticals Act of 2025</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-02-06</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 1060</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250206">February 6, 2025</action-date><action-desc><sponsor name-id="D000230">Mr. Davis of North Carolina</sponsor> (for himself, <cosponsor name-id="R000609">Mr. Rutherford</cosponsor>, and <cosponsor name-id="B001298">Mr. Bacon</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.</official-title></form><legis-body id="HE26C504518E240FDB3460A93D37406F1" style="OLC"><section id="H6F58D71A48E144B2B88D4A8F717CB379" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Modern Authentication of Pharmaceuticals Act of 2025</short-title></quote>.</text></section><section id="HAD241DD1D56B423C9E55338AF976842F"><enum>2.</enum><header>Modernizing the authentication of controlled substances in the pharmaceutical distribution supply chain</header><subsection id="HBF03C09A30464FABACACA843B71BC34A"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Section 582(a)(9) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360eee-1">21 U.S.C. 360eee–1(a)(9)</external-xref>) is amended—</text><paragraph id="H4066EC44F67841A8A1966430F449879B"><enum>(1)</enum><text>in subparagraph (A)(ii), by striking <quote>and</quote> at the end;</text></paragraph><paragraph id="HB5D205CE56F249F6A092A1BCD44812DB"><enum>(2)</enum><text>by redesignating subparagraph (B) as subparagraph (C); and</text></paragraph><paragraph id="H6D0E85998B0C452E82D4D665BA2720F6"><enum>(3)</enum><text>by inserting after subparagraph (A) the following:</text><quoted-block style="OLC" id="H5F9E346801F647BF8FE47D38D2659D93" display-inline="no-display-inline"><subparagraph id="H59C250F5DF854FD592DADB42E7EAC15A"><enum>(B)</enum><text display-inline="yes-display-inline">a physical chemical identifier shall be included in or on each dose of a product that is—</text><clause id="H11E9312AA1844AF6A6565FDE8E1D40A3"><enum>(i)</enum><text>a controlled substance (as defined in section 102 of the Controlled Substances Act);</text></clause><clause id="H16368BA7E2F0449EBEE5403849B5F7EB"><enum>(ii)</enum><text>in solid oral dosage form; and</text></clause><clause id="HEF17E64DDB6E45008A2E09A832FA6835"><enum>(iii)</enum><text display-inline="yes-display-inline">manufactured on or after the date that is five years after the date of enactment of the <short-title>Modern Authentication of Pharmaceuticals Act of 2025</short-title>; and</text></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection><subsection id="H5AA44DCD204341C79DE6CFCF79C1C065"><enum>(b)</enum><header>Conforming changes</header><paragraph id="HEA0BFC9ECD8F4FA38141CD8AA78D40B3"><enum>(1)</enum><text display-inline="yes-display-inline">Section 581(14) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360eee">21 U.S.C. 360eee(14)</external-xref>) is amended to read as follows:</text><quoted-block style="OLC" id="HD8BD4D13283D40B3886200BF0930A213" display-inline="no-display-inline"><paragraph id="H600E3CE75A1C451AAD1FF443B16DCAAE"><enum>(14)</enum><header>Product identifier</header><text display-inline="yes-display-inline">The term <term>product identifier</term> means—</text><subparagraph id="HAB1B2715C184418986F596DEEC9C2B71"><enum>(A)</enum><text>a standardized graphic that includes, in both human-readable form and on a machine-readable data carrier that conforms to the standards developed by a widely recognized international standards development organization, the standardized numerical identifier, lot number, and expiration date of the product; or</text></subparagraph><subparagraph id="HFA97FD57B3BC43B1A8E7D033E9A80F0B"><enum>(B)</enum><text display-inline="yes-display-inline">a physical chemical identifier, possessing a unique physical or chemical substance or combination of substances, that—</text><clause id="H71E4A10184884BB69D72387555C91C41"><enum>(i)</enum><text>is in or on a product;</text></clause><clause id="H6D57C305AFFA4C2BB847ECEB43351D05"><enum>(ii)</enum><text>is machine readable; and</text></clause><clause id="HE6E67B2525E940C6A06CA214318D202E"><enum>(iii)</enum><text>is intended to authenticate the product or a dosage form thereof.</text></clause></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph><paragraph id="H9DDC510719C044AFB69434642DEBCD0E"><enum>(2)</enum><text display-inline="yes-display-inline">Section 581(28) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360eee">21 U.S.C. 360eee(28)</external-xref>) is amended to read as follows:</text><quoted-block style="OLC" id="H737FBB8319E54A399C0F6C7E22CB84AF" display-inline="no-display-inline"><paragraph id="H4C3F1BC74DE44094A387C25FF5C7C8B0"><enum>(28)</enum><header>Verification or verify</header><text display-inline="yes-display-inline">The term <term>verification</term> or <term>verify</term> means—</text><subparagraph id="H482703488E9842999A11CB35BEA0996B"><enum>(A)</enum><text>determining whether the product identifier affixed to, or imprinted upon, a package or homogeneous case corresponds to the standardized numerical identifier or lot number and expiration date assigned to the product by the manufacturer or the repackager, as applicable in accordance with section 582; or</text></subparagraph><subparagraph id="HD8D996CEB7314C52A7C71B4851BFB34E"><enum>(B)</enum><text>determining whether a product or a dosage form thereof is authentic using a physical chemical identifier described in paragraph (14)(B).</text></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection></section></legis-body></bill> 

